Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332) for CNY 8 million on December 29, 2022. As of October 26, 2022, Zhejiang Xianju Pharmaceutical directorate approved transfer of 14.60% stake in Hangzhou Weisibo Medical Technology.